Inventor · disambiguated record
Laure Dumoutier
Also filed as: DUMOUTIER LAURE
11 granted patents·10 pending applications·287 citations·filing 1998–2020
91Inventor score
Files withLUDWIG INST CANCER RES4LUDWIG INST FOR CANCER RES LTD3WYETH CORP3RENAULD JEAN-CHRISTOPHE2DUMOUTIER LAURE1
Top patents by PatentIndex Score
21 records- 0193US10000572B2Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibodyLUDWIG INST FOR CANCER RES LTD·Filed 2014·Granted Jun 19, 2018·22 cites·8 claims
- 0293US6274710B1Antibodies which specifically bind T Cell inducible factors (TIFs)LUDWIG INST CANCER RES·Filed 1998·Granted Aug 14, 2001·94 cites·8 claims
- 0390US6359117B1Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereforLUDWIG INST CANCER RES·Filed 1999·Granted Mar 19, 2002·73 cites·3 claims
- 0489US7972833B2Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereofWYETH LLC·Filed 2007·Granted Jul 5, 2011·10 cites·10 claims
- 0584US7081528B2Isolated nucleic acid molecules encoding T cell derived inducible factorsLUDWIG INST CANCER RES·Filed 2000·Granted Jul 25, 2006·10 cites·4 claims
- 0684US7033787B2Isolated cytokine receptor LICR-2LUDWIG INST CANCER RES·Filed 2001·Granted Apr 25, 2006·13 cites·15 claims
- 0782US6331613B1Isolated nucleic acid molecules which encode T cell inducible factors (TIFS), the proteins encoded, and uses thereofLUDWIG INSTITUE FOR CANCER RES·Filed 1999·Granted Dec 18, 2001·63 cites·22 claims
- 0870US11230603B2Anti-GARP proteinLUDWIG INST FOR CANCER RES LTD·Filed 2020·Granted Jan 25, 2022·0 cites·15 claims
- 0966US10604579B2Antibody against a complex between human GARP and latent TGF-βLUDWIG INST FOR CANCER RES LTD·Filed 2018·Granted Mar 31, 2020·0 cites·5 claims
- 1066US7268223B2Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereofWYETH CORP·Filed 2001·Granted Sep 11, 2007·2 cites·2 claims
- 1159US2009311802A1Isolated Soluble IL-TIF/IL-22 Receptor or Binding Protein Which Binds to IL-TIF/IL-22 and Uses ThereofRENAULD JEAN-CHRISTOPHE·Filed 2009·Application pending·0 cites
- 1256US2004110189A1Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereofFiled 2003·Application pending·0 cites
- 1354US2008064096A1Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereofWYETH CORP·Filed 2007·Application pending·0 cites
- 1452US7846652B2Method for identifying a substance which mediates interaction between interleukin 22 and an interleukin 22 receptorWYETH CORP·Filed 2006·Granted Dec 7, 2010·0 cites·6 claims
- 1549US2005271619A1Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereofDUMOUTIER LAURE·Filed 2005·Application pending·0 cites
- 1648US2004236075A1Novel glass II cytokine receptors, and uses thereofFiled 2002·Application pending·0 cites
- 1747US2003012788A1Method for influencing kinase pathways with IL-22Filed 2002·Application pending·0 cites
- 1846US2004002586A1Crystal structure of interleukin-22 and uses thereofFiled 2002·Application pending·0 cites
- 1944US2002187512A1Crystal structure of human interleukin-22Filed 2002·Application pending·0 cites
- 2040US2005282215A1Isolated cytokine receptor LICR-2RENAULD JEAN-CHRISTOPHE·Filed 2005·Application pending·0 cites
- 2139US2003023033A1Novel class II cytokine receptors and uses thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laure Dumoutier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →